This image depicts Centers for Disease Control and Prevention (CDC), Microbiologist, Dr. Jane Basile, a staff member in the Fort Collins, Colorado, Division of Vector-Borne Diseases (DVBD), who was in the process of preparing reagents that would be used in the CDC-developed Zika IgM antibody-capture enzyme-linked immunosorbent assay (ELISA), referred to as the Zika MAC-ELISA test.
“The Food and Drug Administration (FDA) has issued an Emergency Use Authorization for the CDC Zika IgM Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA) for antibody testing. This assay has been introduced and is being used in qualified public health and Department of Defense laboratories in the United States. The Zika MAC-ELISA is used for the qualitative detection of Zika virus IgM antibodies in serum or cerebrospinal fluid collected from persons meeting the clinical and epidemiologic criteria for suspected Zika virus disease.”
Please note the link below, which leads to more information regarding the interpretation of Zika antibody test results.